サマリー

麻疹ワクチンは、弱毒化した麻疹ウイルスをニワトリ胚細胞に接種し、ウイルス毒を培養・採取した後、凍結乾燥することにより製造されます。上腕の外側三角筋付着部に注射することで、麻疹を予防することができます。
市場の分析と洞察麻疹ワクチンの世界市場
COVID-19の大流行により、麻疹ワクチンの世界市場規模は2022年に百万米ドル相当と推定され、レビュー期間中にCAGR %で2028年までに百万米ドルの再調整サイズになると予測されています。この健康危機による経済変化を十分に考慮し、2021年に麻疹ワクチン世界市場の％を占めた不活化ワクチンは、2028年には百万米ドルの価値を持ち、COVID-19後の期間に修正された％のCAGRで成長すると予測されます。一方、病院セグメントは、この予測期間を通して％CAGRに変更されています。
中国の麻疹ワクチン市場規模は2021年に百万米ドル、米国と欧州の麻疹ワクチンはそれぞれ百万米ドル、百万米ドルと評価されています。米国の割合は2021年に％、中国とヨーロッパはそれぞれ％と％で、中国の割合は2028年に％に達すると予測され、分析期間を通じてCAGRは％となります。日本、韓国、東南アジアはアジアの注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。ヨーロッパの麻疹ワクチン市場については、ドイツは2028年までに100万ドルに達すると予測され、予測期間中のCAGRは%となっています。
麻疹ワクチンの世界的な主要メーカーには、Merck、Biovac、McKesson Medicalなどがあります。2021年には、世界の上位5社が売上高で約 %のシェアを獲得しています。
世界の麻疹ワクチンの範囲とセグメント
麻疹ワクチン市場は、種類別、用途別に分類されています。麻疹ワクチンの世界市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるようになることでしょう。セグメント別分析では、2017年から2028年までのタイプ別およびアプリケーション別の売上、収益、予測に焦点を当てています。
タイプ別セグメント
不活性化ワクチン
弱毒性ワクチン
用途別セグメント
病院
科学研究
その他
会社別
メルク
バイオバック
マッケソンメディカル
地域別
北米
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
U.A.E.

ページTOPに戻る

目次

1 Study Coverage
1.1 Measle Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Measle Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Inactivated Vaccine
1.2.3 Attenuated Vaccine
1.3 Market by Application
1.3.1 Global Measle Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Scientific Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Measle Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Measle Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Measle Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Measle Vaccine Sales by Region
2.4.1 Global Measle Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Measle Vaccine by Region (2023-2028)
2.5 Global Measle Vaccine Revenue by Region
2.5.1 Global Measle Vaccine Revenue by Region (2017-2022)
2.5.2 Global Measle Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Measle Vaccine Sales by Manufacturers
3.1.1 Global Top Measle Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Measle Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Measle Vaccine in 2021
3.2 Global Measle Vaccine Revenue by Manufacturers
3.2.1 Global Measle Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Measle Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Measle Vaccine Revenue in 2021
3.3 Global Measle Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Measle Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Measle Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Measle Vaccine Sales by Type
4.1.1 Global Measle Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Measle Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Measle Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Measle Vaccine Revenue by Type
4.2.1 Global Measle Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Measle Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Measle Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Measle Vaccine Price by Type
4.3.1 Global Measle Vaccine Price by Type (2017-2022)
4.3.2 Global Measle Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Measle Vaccine Sales by Application
5.1.1 Global Measle Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Measle Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Measle Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Measle Vaccine Revenue by Application
5.2.1 Global Measle Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Measle Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Measle Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Measle Vaccine Price by Application
5.3.1 Global Measle Vaccine Price by Application (2017-2022)
5.3.2 Global Measle Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Measle Vaccine Market Size by Type
6.1.1 North America Measle Vaccine Sales by Type (2017-2028)
6.1.2 North America Measle Vaccine Revenue by Type (2017-2028)
6.2 North America Measle Vaccine Market Size by Application
6.2.1 North America Measle Vaccine Sales by Application (2017-2028)
6.2.2 North America Measle Vaccine Revenue by Application (2017-2028)
6.3 North America Measle Vaccine Market Size by Country
6.3.1 North America Measle Vaccine Sales by Country (2017-2028)
6.3.2 North America Measle Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Measle Vaccine Market Size by Type
7.1.1 Europe Measle Vaccine Sales by Type (2017-2028)
7.1.2 Europe Measle Vaccine Revenue by Type (2017-2028)
7.2 Europe Measle Vaccine Market Size by Application
7.2.1 Europe Measle Vaccine Sales by Application (2017-2028)
7.2.2 Europe Measle Vaccine Revenue by Application (2017-2028)
7.3 Europe Measle Vaccine Market Size by Country
7.3.1 Europe Measle Vaccine Sales by Country (2017-2028)
7.3.2 Europe Measle Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Measle Vaccine Market Size by Type
8.1.1 Asia Pacific Measle Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Measle Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Measle Vaccine Market Size by Application
8.2.1 Asia Pacific Measle Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Measle Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Measle Vaccine Market Size by Region
8.3.1 Asia Pacific Measle Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Measle Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Measle Vaccine Market Size by Type
9.1.1 Latin America Measle Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Measle Vaccine Revenue by Type (2017-2028)
9.2 Latin America Measle Vaccine Market Size by Application
9.2.1 Latin America Measle Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Measle Vaccine Revenue by Application (2017-2028)
9.3 Latin America Measle Vaccine Market Size by Country
9.3.1 Latin America Measle Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Measle Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Measle Vaccine Market Size by Type
10.1.1 Middle East and Africa Measle Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Measle Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Measle Vaccine Market Size by Application
10.2.1 Middle East and Africa Measle Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Measle Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Measle Vaccine Market Size by Country
10.3.1 Middle East and Africa Measle Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Measle Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Measle Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Measle Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Biovac
11.2.1 Biovac Corporation Information
11.2.2 Biovac Overview
11.2.3 Biovac Measle Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Biovac Measle Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Biovac Recent Developments
11.3 McKesson Medical
11.3.1 McKesson Medical Corporation Information
11.3.2 McKesson Medical Overview
11.3.3 McKesson Medical Measle Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 McKesson Medical Measle Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 McKesson Medical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Measle Vaccine Industry Chain Analysis
12.2 Measle Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Measle Vaccine Production Mode & Process
12.4 Measle Vaccine Sales and Marketing
12.4.1 Measle Vaccine Sales Channels
12.4.2 Measle Vaccine Distributors
12.5 Measle Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Measle Vaccine Industry Trends
13.2 Measle Vaccine Market Drivers
13.3 Measle Vaccine Market Challenges
13.4 Measle Vaccine Market Restraints
14 Key Findings in The Global Measle Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer